Results 51 to 60 of about 122,678 (147)

Potent neutralizing RBD‐specific antibody cocktail against SARS‐CoV‐2 and its mutant

open access: yesMedComm, 2021
The ongoing pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and its variants has posed a serious global public health emergency.
Lina Jia   +12 more
doaj   +1 more source

First Description of Serological Evidence for SARS-CoV-2 in Lactating Cows

open access: yesAnimals, 2022
Following the COVID-19 epidemic outbreak in Ariano Irpino, Campania region (Italy), we tested lactating cows for the presence of SARS-CoV-2 on a cattle farm at which, prior to the investigation, 13 of the 20 farmworkers showed COVID-19-like symptoms, and
Filomena Fiorito   +11 more
doaj   +1 more source

Antibodies in the breastmilk of COVID-19 recovered women

open access: yesBMC Pregnancy and Childbirth, 2022
Objective Human milk contains antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which may serve as a protective factor through passive immunization in infants.
Paulina Szczygioł   +6 more
doaj   +1 more source

Antibody Response to SARS-CoV-2 among COVID-19 Confirmed Cases and Correlates with Neutralizing Assay in a Subgroup of Patients in Delhi National Capital Region, India

open access: yesVaccines, 2022
Background: The plaque reduction neutralization test (PRNT) is the gold standard to detect the neutralizing capacity of serum antibodies. Neutralizing antibodies confer protection against further infection.
Puneet Misra   +13 more
doaj   +1 more source

Characterizing SARS-CoV-2 antibodies

open access: yesChemical & Engineering News, 2020
ntibody therapeutics will be a key part of the fight against COVID-19, but some do a better job of neutralizing SARS-CoV-2 than others These antibodies stop infection by blocking the virus from entering cells Researchers have now used structural biology techniques and binding assays to show four basic modes by which different neutralizing antibodies ...
openaire   +1 more source

Dissecting antibody-mediated protection against SARS-CoV-2 [PDF]

open access: yesNature Reviews Immunology, 2020
Understanding the properties and mechanisms by which antibodies provide protection is essential to defining immunity. Although neutralizing antibodies have been proposed as a potential key mechanism of protection against many viral pathogens, antibodies mediate additional immune functions that may have both protective and pathological consequences ...
Zohar, Tomer, Alter, Galit
openaire   +2 more sources

Sequentially immune‐induced antibodies could cross‐neutralize SARS‐CoV‐2 variants

open access: yesAnimal Models and Experimental Medicine, 2022
Background The Omicron (B.1.1.529) SARS‐COV‐2 variant has raised serious concerns because of its unprecedented rapid rate of spreading and the fact that there are 36 mutations in the spike protein.
Qi Lv   +6 more
doaj   +1 more source

Neutralizing and enhancing antibodies against SARS-CoV-2

open access: yesInflammation and Regeneration, 2022
AbstractThe high transmissibility and rapid global spread of SARS-CoV-2 since 2019 has led to a huge burden on healthcare worldwide. Anti-SARS-CoV-2 neutralizing antibodies play an important role in not only protecting against infection but also in clearing the virus and are essential to providing long-term immunity.
Yafei Liu, Hisashi Arase
openaire   +3 more sources

Retrained Generic Antibodies Can Recognize SARS-CoV-2 [PDF]

open access: yesThe Journal of Physical Chemistry Letters, 2020
The dramatic impact which novel viruses can have on the human society could be mitigated without the need of vaccination if antibodies present within the population are retrained to recognize these viruses. With this idea in mind, a double-faced peptide-based boosters are computationally designed to allow recognition of SARS-CoV-2 by Hepatitis B ...
Han, Yanxiao   +2 more
openaire   +3 more sources

Binding and neutralizing abilities of antibodies towards SARS-CoV-2 S2 domain

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants have been reported to be resistant to several neutralizing antibodies (NAbs) targeting Receptor Binding Domain (RBD) and N Terminal Domain (NTD) of spike (S) protein and thus inducing ...
Xingsu Gao   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy